Dr. Ma, master supervisor, once worked in the General Surgery Department of Changhai Hospital and Eastern Hepatobiliary Surgery Hospital affiliated to Second Military Medical University.
He once studied in department of General Surgery at St. Luke's Medical Center of RUSH University Medical School in Chicago as a visiting scholar. He is proficient in all kinds of general surgery, and also good at Hepatobiliary, Pancreatic and Splenic surgery, Gastrointestinal surgery, Thyroid and Breast surgery.
After more than 30 years of accumulated clinical experience, he has successfully completed nearly 600 cases of modified Sugiura surgeries, and more than 500 cases of Whipple procedure by using the improved digestive tract reconstruction method and the pancreaticojejunostomy method. All the patients had obtained good therapeutic effect after surgery.
Dr. Ma has published a total of 40 academic papers and participated in the compilation of 9 monographs. In 2012, he was awarded one of the top 100 Famous Doctors in China and has won Second and Third prizes for Military Medical Achievement.
Zhang Junchu, deputy chief physician and master supervisor, once worked in the Department of General Surgery of Changzheng Hospital affiliated to the Second Military Medical University. He has been engaged in clinical work of general surgery for more than 30 years. Skilled in the treatment of common, frequenty-occurring and difficult diseases in general surgery, he is especially good at the diagnosis and treatment of thyroid and breast diseases. Up to now, he has completed more than 5000 cases of thyroid and breast diseases, including more than 400 cases of bilateral giant goiter and giant retrosternal goiter.
In terms of breast cancer, on the basis of simple mastectomy and modified radical mastectomy, Dr. Zhang carried out breast conservation surgery and breast endoscopic axillary lymph node dissection and other new surgical methods, which not only treated the disease, but also preserved the function of mammary gland and the fine body shape of woman. And those were deeply welcomed by patients.
Dr. Zhang has published more than 20 papers in influential journals in China. He has won a Third Prize for military Scientific and Technological Progress, a Youth Fund of the PLA and a fund of Shanghai Science and Technology Commission.
Associate chief physician/Associate professor
Member of Chinese Medical Association and Anti-cancer Association
Former Deputy Chairman of the Hematologic Oncology Committee of the Beijing Military Region
Former Associate professor/Grade A faculty member of the Second Military Medical University
Member of the expert bank of disability and disease identification of the Former Beijing Military area Command
Member of the youth Committee of Hematologic Oncology of the PLA
Project appraisal committee member of Natural Fund of Beijing Science and Technology Commission
Member of Precision Medicine Branch of China Medical Biotechnology Association
Dr. Lou specializes in the diagnosis and treatment of various clinical hematopathy, such as various anemia, myelodysplastic syndrome, leukemia, lymphoma, myeloma, etc. He has done extensive research on allogeneic hematopoietic stem cell transplants for diseases such as aplastic anemia, paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, leukemia, lymphoma, and multiple myeloma.
Since 2015, Dr. Lou has been engaged in immunotherapy for hematologic tumors and solid tumors, especially DC vaccine, immunocheckpoint inhibitor (PD1 monoclonal antibody) therapy and CART cell therapy for various advanced solid tumors. He has rich clinical experience in the management of adverse reactions caused by chemotherapy, targeted drugs combined with immunotherapy and immunotherapy when treating tumors.
Dr. Lou has published more than 60 papers in various journals at home and abroad, and participated in the compilation of 2 professional books.
He is a founding member of CSCO and a two-term member of Hematologic Branch of Shanghai Medical Association. He has also been collected in Shanghai Expert database of Medical Malpractice Identification.
Dr. Wang graduated from the Department of Medicine of Shanghai First Medical College in 1983.
From 1983 to 2009, he served successively as Resident/Attending physician, Associate Professor and Deputy Director of Administration in the Hematology Department of Changzheng Hospital, and then transferred to the Department of Oncology as associate professor in 2010.
Dr. Wang has been rooted in the frontline of clinical work for a long time, which enables him to master the solid basic knowledge of internal medicine. He also has a lot of rich experience in the diagnosis and treatment of difficult cases and autoimmune diseases in Hematology Department. He is particularly good at the treatment of recurrent refractory leukemia, lymphoma and multiple myeloma.
In recent years, Dr. Wang has made profound research in the diagnosis, chemorotherapy and immune-targeted therapy of solid tumors, and has a good grasp of relevant indications. He also has unique insights in the palliative treatment of elderly or advanced solid tumors.
Dr. Ren once worked at the Beijing Clinical Medical College of former Second Military Medical University, and served as a tutor for postgraduate students at Southern Medical University.
He owns many professional positions, including: member of hepatology Committee of Chinese Research Hospital Association, member of integrated Chinese and Western medicine Oncology Committee of Chinese Anti-cancer Association, member of Translational Medicine Branch of China Pharmaceutical Quality Management Association, member of Hepatology of Liver Cancer study group of Beijing Medical Association, member of the Infectious Diseases Professional Committee of former Beijing Military Command, Beijing Medical malpractice expert, and tec.
Dr. Ren is very good at diagnosis and treatment of many diseases, such as viral hepatitis, liver cirrhosis, primary liver cancer, fatty liver disease, autoimmune liver disease, drug-induced hepatotoxicity and so on. And he is particularly good at the non-surgical treatment (ablation treatment) and comprehensive treatment of primary liver cancer.
As a member of the Oncology Committee of the Chinese Medical Association, member of the CSCO, and member of the expert database of Medical Malpractice Technical appraisal of the Provincial Medical Association, Dr. Xue has been working in the GradeⅢ & Class A hospitals for over 30 years. Therefore, he has accumulated rich clinical experience in the combination therapy of Chemotherapy, Radiotherapy, Interventional therapy, Endocrine therapy, Molecular Targeted therapy and Biological therapy for malignant solid tumors. He is also highly accomplished in the diagnosis and treatment of lung tumors, gastrointestinal tumors, nasopharyngeal cancer, breast cancer and cervical cancer.
Dr. Xue not only advocates the early implementation of multidisciplinary consultation (MDT) and the formulation of a whole-process individualized diagnosis and treatment strategy for patients, but also hopes to use the most advanced technology to optimize the treatment of cancer patients, so as to relieve the pain, improve the quality of life and prolong the survival time of cancer patients.
In 2003, he went to Xiaotangshan Hospital in Beijing to fight against SARS and won the title of “Hero against SARS”. In 2005, he performed UN peacekeeping medical mission abroad for one year and won the UN Peacekeeping Medal.
Dr. Xue has published more than 20 papers in domestic and foreign medical journals, and participated in the editing of a monograph "Radiotherapy for Cervical Cancer".
M.D., associate chief physician/associate professor, Shanghai Pujiang Talent, postgraduate supervisor
Dr.Wang once worked in gastroenterology/endoscopy department of Eastern Hepatobiliary Surgery Hospital and Gastroenterology Department of Changzheng Hospital. He has spent two years at the Postdoctoral workstation at the Mary Babb Randolph Cancer Research Center at West Virginia University Health Science Center.
Dr. Wang used to be a member of the Digestive endoscopy ESD Group and the digestive oncology Group of Shanghai Medical Association, as well as a member of the Expert bank of Shanghai Science and Technology Commission, the national online evaluation expert Bank of doctoral dissertations, and the National Natural Science Foundation of China.
Dr. Wang has more than 30 years of experience in the diagnosis and treatment of digestive diseases, diagnosis and interventional treatment of diseases related to digestive endoscopy. He specializes in the diagnosis and treatment of many gastrointestinal diseases such as gastroesophageal reflux disease, peptic ulcer, functional dyspepsia, chronic diarrhea, chronic constipation, inflammatory bowel disease and has rich clinical experience in the diagnosis and treatment of liver and gallbladder diseases and pancreatic diseases. With the assistance of digestive endoscopy, he is also good at the resection of small lesions under gastroenteroscopy, stent placement, endoscopic ultrasonography, common bile duct extraction under ERCP, stent placement for benign and malignant bile duct strictures, and other technical surgeries.
Dr. Wang once undertook one project funded by the National Natural Science Foundation of China (2011) as the first person in charge, two projects funded by the National Natural Science Foundation of China as the second person in charge, and one project funded by Youth Fund of the Military Medical and Health as the first person in charge.
He has won many awards and honors, namely: the Third prize of Science and Technology Progress Award of the PLA, Third-class Merit in the army, Second Military Medical University Award，Changzheng Hospital Award, Outstanding Communist, and Advanced individual of the teaching in Second Military Medical University, and etc.
Dr. Wang has published more than 20 academic papers, including 12 core journal papers as the first author and 7 SCI papers. Among the SCI papers, 2 have been published as the first author and 1 as the corresponding author, among which the impact factor is as high as 5.2. He has co-edited and published a total of 7 monographs.
As the former director of the Radiotherapy Center of the 85th Hospital of the PLA, Gao has personally participated in the diagnosis and treatment of more than 40,000 patients, so he has accumulated extremely rich clinical experience in cancer radiotherapy.
Dr.Gao is one of the early professionals engaged in tumor radiotherapy and stereotactic radiotherapy in China. He has held various roles, including: the first member of Technical Committee for Precise Radiotherapy of Chinese Biomedical Engineering Society, the standing committee of Gamma-ray Stereotactic Radiotherapy Technology Group, member of Professional Committee of Minimally Invasive Treatment of tumor of Shanghai Anti-Cancer Association, and member of Minimally invasive Oncology Medical Professional Committee of Shanghai Society of Integrated Chinese and Western Medicine.
He has published many papers in domestic medical journals, including the analysis of the therapeutic effect of Three-dimensional adaptive intensity modulation in 118 cases of pancreatic cancer and the therapeutic effect of Gamma-ray radiotherapy in the treatment of liver cancer.